1. Home
  2. BSVN vs ATYR Comparison

BSVN vs ATYR Comparison

Compare BSVN & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSVN
  • ATYR
  • Stock Information
  • Founded
  • BSVN 2004
  • ATYR 2005
  • Country
  • BSVN United States
  • ATYR United States
  • Employees
  • BSVN N/A
  • ATYR N/A
  • Industry
  • BSVN Major Banks
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BSVN Finance
  • ATYR Health Care
  • Exchange
  • BSVN Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • BSVN 335.6M
  • ATYR 306.2M
  • IPO Year
  • BSVN 2018
  • ATYR 2015
  • Fundamental
  • Price
  • BSVN $38.34
  • ATYR $5.35
  • Analyst Decision
  • BSVN Buy
  • ATYR Strong Buy
  • Analyst Count
  • BSVN 2
  • ATYR 6
  • Target Price
  • BSVN $51.00
  • ATYR $18.60
  • AVG Volume (30 Days)
  • BSVN 21.3K
  • ATYR 2.0M
  • Earning Date
  • BSVN 07-10-2025
  • ATYR 05-07-2025
  • Dividend Yield
  • BSVN 2.49%
  • ATYR N/A
  • EPS Growth
  • BSVN 46.15
  • ATYR N/A
  • EPS
  • BSVN 4.71
  • ATYR N/A
  • Revenue
  • BSVN $96,026,000.00
  • ATYR N/A
  • Revenue This Year
  • BSVN N/A
  • ATYR $1,093.62
  • Revenue Next Year
  • BSVN $3.53
  • ATYR $1,129.59
  • P/E Ratio
  • BSVN $8.22
  • ATYR N/A
  • Revenue Growth
  • BSVN 28.97
  • ATYR N/A
  • 52 Week Low
  • BSVN $27.84
  • ATYR $1.42
  • 52 Week High
  • BSVN $50.26
  • ATYR $5.75
  • Technical
  • Relative Strength Index (RSI)
  • BSVN 51.40
  • ATYR 77.06
  • Support Level
  • BSVN $36.91
  • ATYR $4.16
  • Resistance Level
  • BSVN $39.68
  • ATYR $5.75
  • Average True Range (ATR)
  • BSVN 1.06
  • ATYR 0.40
  • MACD
  • BSVN -0.00
  • ATYR 0.18
  • Stochastic Oscillator
  • BSVN 56.31
  • ATYR 85.19

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: